🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells ...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2004-01-23
Trial ID
NCT00075946
Treatments Being Tested
This study will evaluate whether a reduction in the radiation dose and fiel...
Status
Completed
Location
Durham Regional Hospital
Start Date
2010-09-20
Trial ID
NCT01186978
Treatments Being Tested
This is a single-center, prospective, randomized, open-label clinical trial...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2026-07-09
Trial ID
NCT07703657
Treatments Being Tested
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
Monoclonal antibodies such as rituximab can locate cancer cells and either ...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2000-12
Trial ID
NCT00010192
Treatments Being Tested
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
This phase II trial studies how well vorinostat and combination chemotherap...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-29
Trial ID
NCT04220008